John W. Hubbard

At Issue: Defining Treatment Refractoriness in Schizophrenia

H. D. Brenner, S. J. Dencker, Michael J. Goldstein et al. · Schizophrenia Bulletin · 1990 · 246 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +11

A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia

Don Goff, Enrico Amico, Ofra Sarid‐Segal et al. · Psychopharmacology · 1995 · 148 citations

Pharmacy, Pharmacotherapy, Psychiatry +12

Effects of stress on blood pressure and cardiac pathology in rats with borderline hypertension.

James E. Lawler, Gregory F. Barker, John W. Hubbard et al. · Hypertension · 1981 · 141 citations · Full text

Veterinary Medicine, Physiology, Psychology +15

Enantioselective pharmacokinetics and pharmacodynamics of dl-thero-mcthylphenidate in children with attention deficit hyperactivity disorder

Nuggehally R Srinivas, John W. Hubbard, Declan Quinn et al. · Clinical Pharmacology & Therapeutics · 1992 · 121 citations

Medicine, Pharmacokinetics, Pharmacology +17

Enantioselective Pharmacokinetics of dl-threo-Methylphenidate in Humans

Nuggehally R. Srinivas, John W. Hubbard, E. D. Korchinski et al. · Pharmaceutical Research · 1993 · 106 citations

Medicine, Pharmacokinetics, Pharmacology +7